2024 Q4 Form 10-Q Financial Statement

#000147615024000016 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $99.64M
YoY Change 20.16%
Cost Of Revenue $25.60M
YoY Change 25.06%
Gross Profit $74.04M
YoY Change 18.55%
Gross Profit Margin 74.31%
Selling, General & Admin $10.78M
YoY Change 18.16%
% of Gross Profit 14.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.06M
YoY Change 31.86%
% of Gross Profit 32.5%
Operating Expenses $34.83M
YoY Change 27.29%
Operating Profit $39.20M
YoY Change 11.73%
Interest Expense -$2.553M
YoY Change -143.91%
% of Operating Profit -6.51%
Other Income/Expense, Net -$2.553M
YoY Change -45.92%
Pretax Income $36.64M
YoY Change 20.86%
Income Tax
% Of Pretax Income
Net Earnings $36.64M
YoY Change 20.86%
Net Earnings / Revenue 36.77%
Basic Earnings Per Share $0.37
Diluted Earnings Per Share $0.37
COMMON SHARES
Basic Shares Outstanding 99.74M shares 96.90M shares
Diluted Shares Outstanding 97.87M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $243.7M
YoY Change 153.31%
Cash & Equivalents $243.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $243.7M
YoY Change 153.31%
LONG-TERM ASSETS
Property, Plant & Equipment $4.227B
YoY Change 18.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.11M
YoY Change -1.66%
Total Long-Term Assets $4.327B
YoY Change 18.77%
TOTAL ASSETS
Total Short-Term Assets $243.7M
Total Long-Term Assets $4.327B
Total Assets $4.571B
YoY Change 22.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.95M
YoY Change 23.27%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $176.2M
YoY Change 22.37%
LONG-TERM LIABILITIES
Long-Term Debt $672.2M
YoY Change -12.86%
Other Long-Term Liabilities $91.25M
YoY Change 4.67%
Total Long-Term Liabilities $763.4M
YoY Change -11.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $176.2M
Total Long-Term Liabilities $763.4M
Total Liabilities $939.6M
YoY Change -6.28%
SHAREHOLDERS EQUITY
Retained Earnings $68.06M
YoY Change -11.7%
Common Stock $3.595B
YoY Change 33.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.631B
YoY Change
Total Liabilities & Shareholders Equity $4.571B
YoY Change 22.23%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $36.64M
YoY Change 20.86%
Depreciation, Depletion And Amortization $24.06M
YoY Change 31.86%
Cash From Operating Activities $69.99M
YoY Change 31.41%
INVESTING ACTIVITIES
Capital Expenditures $50.42M
YoY Change -14.15%
Acquisitions
YoY Change
Other Investing Activities -$7.898M
YoY Change -45.19%
Cash From Investing Activities -$58.32M
YoY Change -20.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.81M
YoY Change -17.1%
NET CHANGE
Cash From Operating Activities 69.99M
Cash From Investing Activities -58.32M
Cash From Financing Activities 49.81M
Net Change In Cash 61.48M
YoY Change 52.93%
FREE CASH FLOW
Cash From Operating Activities $69.99M
Capital Expenditures $50.42M
Free Cash Flow $19.57M
YoY Change -457.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243670000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
165400000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
261000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
836000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
88960000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
75081000 usd
CY2024Q3 us-gaap Assets
Assets
4570871000 usd
CY2024Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
199321000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
199145000 usd
CY2024Q3 us-gaap Senior Notes
SeniorNotes
472836000 usd
CY2024Q3 us-gaap Security Deposit Liability
SecurityDepositLiability
37351000 usd
CY2023Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
32934000 usd
CY2024Q3 us-gaap Below Market Lease Net
BelowMarketLeaseNet
91250000 usd
CY2023Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
84718000 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48871000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
39052000 usd
CY2024Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
89947000 usd
CY2023Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
61783000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
939576000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
990050000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87487098 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
994000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
876000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3594034000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2849961000 usd
CY2024Q3 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
31788000 usd
CY2023Q4 us-gaap Common Stock Held In Trust
CommonStockHeldInTrust
31788000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
68055000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
95578000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3631295000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2914627000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4570871000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3904677000 usd
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
99635000 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
82920000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
278912000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
237106000 usd
CY2024Q3 us-gaap Revenues
Revenues
99635000 usd
CY2023Q3 us-gaap Revenues
Revenues
82920000 usd
us-gaap Revenues
Revenues
278912000 usd
us-gaap Revenues
Revenues
237106000 usd
CY2024Q3 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
25599000 usd
CY2023Q3 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
20469000 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
70261000 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
57436000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18245000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
68009000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
54636000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9119000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31828000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28205000 usd
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
47000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
126000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
60443000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
47884000 usd
us-gaap Costs And Expenses
CostsAndExpenses
170145000 usd
us-gaap Costs And Expenses
CostsAndExpenses
140403000 usd
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2347000 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1093000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
9572000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
4029000 usd
CY2024Q3 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2803000 usd
us-gaap Net Income Loss
NetIncomeLoss
108394000 usd
us-gaap Net Income Loss
NetIncomeLoss
93900000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
150000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
437000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36483000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36483000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
30165000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
30165000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
93463000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
93463000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97561792 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84041413 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94253923 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
82366365 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97870794 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84266740 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94598279 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82597824 shares
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
392503000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34603
dei Entity Registrant Name
EntityRegistrantName
Terreno Realty Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1262675
dei Entity Address Address Line1
EntityAddressAddressLine1
10500 NE 8th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellevue
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98004
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
655-4580
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
TRNO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
99735692 shares
CY2024Q3 us-gaap Land
Land
2348670000 usd
CY2023Q4 us-gaap Land
Land
1995494000 usd
CY2024Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1858948000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1561532000 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
287804000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
343485000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
177258000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
147329000 usd
CY2024Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
4672680000 usd
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
4047840000 usd
CY2024Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
445544000 usd
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
384480000 usd
CY2024Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
4227136000 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3663360000 usd
CY2024Q3 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
10844000 usd
CY2023Q4 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
0 usd
CY2024Q3 us-gaap Real Estate Investments
RealEstateInvestments
4237980000 usd
CY2023Q4 us-gaap Real Estate Investments
RealEstateInvestments
3663360000 usd
CY2023Q4 us-gaap Assets
Assets
3904677000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99227029 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99227029 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87487098 shares
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10775000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
51000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
466000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2914627000 usd
CY2023Q3 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
3500000 usd
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
12400000 usd
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
10700000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1690000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4026000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100222000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72139000 usd
CY2023Q4 trno Straight Line Rent And Accounts Receivables Net Of Allowances
StraightLineRentAndAccountsReceivablesNetOfAllowances
56100000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
13500000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
5715000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
12257000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2553000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4721000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-373000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
36639000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
30315000 usd
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
156000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
36059000 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3226000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
535042000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
983000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3356000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
43517000 usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1910
dei Entity Shell Company
EntityShellCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001476150
CY2023Q4 us-gaap Senior Notes
SeniorNotes
572418000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24058000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4900000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5814000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15660000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
19089000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
107928000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
107928000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3444584000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
35696000 usd
CY2024Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
55000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3988000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
43529000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3440685000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
36639000 usd
CY2024Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3088000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
201371000 usd
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2306000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3777000 usd
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.49
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
48871000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3631295000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2229851000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
23331000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
943000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
377488000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
627000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3038000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
33209000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2599872000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
40254000 usd
CY2023Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
822000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37903000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
105000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3805000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
33465000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2648264000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
30315000 usd
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1438000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
94309000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
773000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3280000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
38425000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2736970000 usd
us-gaap Net Income Loss
NetIncomeLoss
108394000 usd
us-gaap Net Income Loss
NetIncomeLoss
93900000 usd
us-gaap Straight Line Rent
StraightLineRent
6517000 usd
us-gaap Straight Line Rent
StraightLineRent
6510000 usd
trno Amortization Of Lease Intangibles
AmortizationOfLeaseIntangibles
12414000 usd
trno Amortization Of Lease Intangibles
AmortizationOfLeaseIntangibles
10681000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
68009000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
54636000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
5715000 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
12257000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1148000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1157000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11121000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10123000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2745000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4447000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20080000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14705000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
181361000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
140626000 usd
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
476832000 usd
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
10172000 usd
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
24585000 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
108148000 usd
us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
72449000 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
30635000 usd
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
39270000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-605443000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-479637000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
742728000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
512902000 usd
trno Issuance Costs On Issuance Of Common Stock
IssuanceCostsOnIssuanceOfCommonStock
5704000 usd
trno Issuance Costs On Issuance Of Common Stock
IssuanceCostsOnIssuanceOfCommonStock
2740000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3344000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1505000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
49000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49000000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
100000000 usd
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5805000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
80000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
126098000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
97427000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
501777000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
411150000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77695000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72139000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166236000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28083000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243931000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100222000 usd
us-gaap Interest Paid Net
InterestPaidNet
24733000 usd
us-gaap Interest Paid Net
InterestPaidNet
24156000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
36104000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29441000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
5672000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2264000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
trno Reconciliation Acquisition Of Properties
ReconciliationAcquisitionOfProperties
499415000 usd
trno Reconciliation Acquisition Of Properties
ReconciliationAcquisitionOfProperties
436980000 usd
trno Assumptions Of Other Assets And Liabilities
AssumptionsOfOtherAssetsAndLiabilities
22583000 usd
trno Assumptions Of Other Assets And Liabilities
AssumptionsOfOtherAssetsAndLiabilities
44477000 usd
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
476832000 usd
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
392503000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
6 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</span></div>
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q3 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
4600000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P6Y1M6D
CY2024Q3 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
156160000 usd
CY2024Q3 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
64910000 usd
CY2024Q3 us-gaap Below Market Lease Net
BelowMarketLeaseNet
91250000 usd
CY2023Q4 us-gaap Below Market Lease Gross
BelowMarketLeaseGross
137047000 usd
CY2023Q4 us-gaap Below Market Lease Accumulated Amortization
BelowMarketLeaseAccumulatedAmortization
52329000 usd
CY2023Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
84718000 usd
CY2024Q3 trno Finite Lived Intangible Assets Liabilities Gross
FiniteLivedIntangibleAssetsLiabilitiesGross
21827000 usd
CY2024Q3 trno Finite Lived Intangible Assets Liabilities Accumulated Amortization
FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization
46363000 usd
CY2024Q3 trno Finite Lived Intangible Assets Liabilities Net
FiniteLivedIntangibleAssetsLiabilitiesNet
-24536000 usd
CY2023Q4 trno Finite Lived Intangible Assets Liabilities Gross
FiniteLivedIntangibleAssetsLiabilitiesGross
10282000 usd
CY2023Q4 trno Finite Lived Intangible Assets Liabilities Accumulated Amortization
FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization
44610000 usd
CY2023Q4 trno Finite Lived Intangible Assets Liabilities Net
FiniteLivedIntangibleAssetsLiabilitiesNet
-34328000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
165400000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26393000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
836000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
166236000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28083000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243670000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96196000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
261000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
243931000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77695000 usd
CY2024Q3 trno Straight Line Rent And Accounts Receivables Net Of Allowances
StraightLineRentAndAccountsReceivablesNetOfAllowances
60300000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2500000 usd
CY2024Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
14600000 usd
trno Share Based Compensation Performance Measurement Period
ShareBasedCompensationPerformanceMeasurementPeriod
P3Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2700000 usd
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2600000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
8700000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
5500000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
675000000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
675000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
775000000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2843000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3437000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
672157000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
771563000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
50000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
150000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
200000000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
275000000 usd
CY2024Q3 trno Long Term Debt Before Net Debt Issuance Costs
LongTermDebtBeforeNetDebtIssuanceCosts
675000000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2843000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
672157000 usd
CY2024Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.040
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
72351000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292569000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
255549000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
199994000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
148346000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
315971000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1284780000 usd
CY2024Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
635262000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
672157000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
721269000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
771563000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2976266 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5329544 shares
CY2024Q3 trno Sales Of Stock Weighted Average Offering Price
SalesOfStockWeightedAverageOfferingPrice
68.70
trno Sales Of Stock Weighted Average Offering Price
SalesOfStockWeightedAverageOfferingPrice
66.62
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1575173 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2542279 shares
CY2023Q3 trno Sales Of Stock Weighted Average Offering Price
SalesOfStockWeightedAverageOfferingPrice
60.78
trno Sales Of Stock Weighted Average Offering Price
SalesOfStockWeightedAverageOfferingPrice
61.61
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
94400000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
154400000 usd
CY2023Q3 trno Fees And Commissions At Market Equity Offering Program Sales Agent
FeesAndCommissionsAtMarketEquityOfferingProgramSalesAgent
1400000 usd
trno Fees And Commissions At Market Equity Offering Program Sales Agent
FeesAndCommissionsAtMarketEquityOfferingProgramSalesAgent
2300000 usd
CY2024Q3 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3000000 shares
trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
CY2023Q3 trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
CY2024Q3 trno Stock Withdrawn During Period From Deferred Compensation Plan
StockWithdrawnDuringPeriodFromDeferredCompensationPlan
0 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
426887 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.49
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
422856 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
404010 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
430782 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
384239 shares
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001476150-24-000016-index-headers.html Edgar Link pending
0001476150-24-000016-index.html Edgar Link pending
0001476150-24-000016.txt Edgar Link pending
0001476150-24-000016-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trno-20240930.htm Edgar Link pending
trno-20240930.xsd Edgar Link pending
trnoq32024ex-311.htm Edgar Link pending
trnoq32024ex-312.htm Edgar Link pending
trnoq32024ex-313.htm Edgar Link pending
trnoq32024ex-321.htm Edgar Link pending
trnoq32024ex-322.htm Edgar Link pending
trnoq32024ex-323.htm Edgar Link pending
trno-20240930_def.xml Edgar Link unprocessable
trno-20240930_lab.xml Edgar Link unprocessable
trno-20240930_pre.xml Edgar Link unprocessable
trno-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
trno-20240930_cal.xml Edgar Link unprocessable